Overview
The COVID-19 pandemic has unquestionably altered the world, including the job market. In this webinar, we will explore the changes the pandemic has brought to the professional world, specifically in life science legal careers. Join our panel of experienced professionals and career coach as they reflect on how the pandemic has influenced their organization; shifts in hiring and retention practices; and advice for young professionals evaluating their careers for 2021 and beyond.
Speakers
Stuart TenHoor, President, Stuart TenHoor Legal Search
Stacy Amin, Partner, Morrison and Foerster, LLP
Nathan Brown, Partner, Akin Gump Strauss Hauer & Feld LLP
Freddy A. Jimenez, Senior Vice-President and General Counsel, Celldex Therapeutics, Inc.
NATHAN A. BROWN is a partner in the Health Care and Life Sciences practice at Akin Gump. He has worked extensively in the FDA regulatory and compliance field and is sought after for his understanding and insights into the regulation and marketing of innovative medical technologies. He previously served in prominent roles at the Food and Drug Administration and as an FDA advisor to the Senate HELP Committee. He currently serves on the Food and Drug Law Journal Editorial Advisory Board.
FREDDY A. JIMENEZ is Vice-President, Law and Compliance at Celldex Therapeutics. Freddy brings over 25 years of experience in the biopharmaceutical industry. At Celldex he is chief lawyer and compliance officer responsible for the development and execution of comprehensive legal and compliance strategies as well as coordination of legal services to support the R&D and commercial efforts of Celldex. Significant contributions have included leading the legal team supporting the acquisition and integration of Kolltan Pharmaceuticals, designing and launching Celldex’s health care compliance program, and revamping the contracting process. Prior to Celldex, he was at Johnson & Johnson (J&J) for 23 years in various roles, including as head of the pharmaceutical regulatory legal group for J&J where he coordinated legal strategy, deployment, and provided advice and counsel regarding regulatory, compliance, and fraud and abuse matters to pharmaceutical and biopharmaceutical affiliates of J&J and to the North America Leadership Team. He is a recipient of six J&J Standards of Leadership Awards. He is on the Board of Directors and is General Counsel for the Food and Drug Law Institute and is a graduate of Brandeis University and the Rutgers School of Law – Newark.Register
This program is limited to those who are a part of NFDL.
New to Food and Drug Law Group
The New to Food and Drug Law Group (NFDL) offers young professionals with up to six years of experience an opportunity to connect, learn from their peers, and enhance their skills. Individuals affiliated with member organizations, those employed by the government, and law students are encouraged to participate.
